2-38666223-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138801.3(GALM):āc.62A>Gā(p.Lys21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_138801.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALM | NM_138801.3 | c.62A>G | p.Lys21Arg | missense_variant | 1/7 | ENST00000272252.10 | NP_620156.1 | |
GALM | XM_011532540.3 | c.62A>G | p.Lys21Arg | missense_variant | 1/6 | XP_011530842.1 | ||
GALM | XM_047443419.1 | c.62A>G | p.Lys21Arg | missense_variant | 1/6 | XP_047299375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALM | ENST00000272252.10 | c.62A>G | p.Lys21Arg | missense_variant | 1/7 | 1 | NM_138801.3 | ENSP00000272252.5 | ||
GALM | ENST00000410063.5 | c.62A>G | p.Lys21Arg | missense_variant | 1/4 | 3 | ENSP00000386233.1 | |||
GALM | ENST00000427858.4 | n.143A>G | non_coding_transcript_exon_variant | 1/4 | 4 | |||||
GALM | ENST00000444351.5 | n.-20A>G | upstream_gene_variant | 5 | ENSP00000409083.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250944Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135670
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461754Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727186
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
GALM-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 26, 2024 | The GALM c.62A>G variant is predicted to result in the amino acid substitution p.Lys21Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at